MD Anderson Events
Ethics Seminar Series: The 'Myriad' Dilemma: Should We Be Able To Patent Our Genes?
The session will consider how healthcare professionals sometimes encounter ethical challenges in their practice. These individuals will gain insight into the current debate involving the nexus between the drive to provide innovative therapies and better patient outcomes with the incentives for health care entrepreneurship and remuneration. At the core of this intellectual property policy debate is the impact and reliance we have on technology/diagnostics as well as the fundamental question of "do we own our bodies?" This presentation will explore some of these issues and open a discussion to address them for social workers, physicians, nurses and ethicists.
Date: 6/11/13, 12pm to 1pm
Time: 6/11/13, 12pm to 1pm
Directions: Pickens Academic Tower
CME: The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit TM
Facilitator: Jessica A. Moore, DHCE
Speaker: Jeff Farroni, PhD, JD
Contact: Brittany Campbell - (713) 794-1495 - firstname.lastname@example.org
Ethics Seminar Announcment_ June 2013.pdf (PDF, 518 KB)
- Thoracic, Head and Neck Cancer Research Seminar
- Department of Radiation Oncology Special Seminar
- Department of Molecular & Cellular Oncology Seminar
- S2M Science to Medicine Seminar "Regulation of Enhancer Overactivation by a Protein Complex Containing RACK7/ZMYND8 and KDM5C"
- Annual Postdoctoral Science Symposium
- Department of Translational Molecular Pathology Distinguished Speaker Seminar Series
- Dr. Mina Bissell: Why don’t we get more cancer: The critical role of Extracellular Matrix and Microenvironment in metastasis and dormancy
- S2M Science to Medicine Seminar Series "Mitochondria and Metal-Induced Oxidative Stress at the Center of Alzheimer Disease"
- Updates in Palliative Care and Physician Board Review Course
- New Immune Checkpoints, New Cancer Immunotherapies